Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
HNF1α maintains pancreatic α and β cell functions in primary human islets
Mollie F. Qian, … , Patrick E. MacDonald, Seung K. Kim
Mollie F. Qian, … , Patrick E. MacDonald, Seung K. Kim
Published November 9, 2023
Citation Information: JCI Insight. 2023;8(24):e170884. https://doi.org/10.1172/jci.insight.170884.
View: Text | PDF
Research Article Endocrinology Genetics

HNF1α maintains pancreatic α and β cell functions in primary human islets

  • Text
  • PDF
Abstract

HNF1A haploinsufficiency underlies the most common form of human monogenic diabetes (HNF1A–maturity onset diabetes of the young [HNF1A-MODY]), and hypomorphic HNF1A variants confer type 2 diabetes risk. But a lack of experimental systems for interrogating mature human islets has limited our understanding of how the transcription factor HNF1α regulates adult islet function. Here, we combined conditional genetic targeting in human islet cells, RNA-Seq, chromatin mapping with cleavage under targets and release using nuclease (CUT&RUN), and transplantation-based assays to determine HNF1α-regulated mechanisms in adult human pancreatic α and β cells. Short hairpin RNA–mediated (shRNA-mediated) suppression of HNF1A in primary human pseudoislets led to blunted insulin output and dysregulated glucagon secretion after transplantation in mice, recapitulating phenotypes observed in patients with diabetes. These deficits corresponded with altered expression of genes encoding factors critical for hormone secretion, including calcium channel subunits, ATPase transporters, and extracellular matrix constituents. Additionally, HNF1A loss led to upregulation of transcriptional repressors, providing evidence for a mechanism of transcriptional derepression through HNF1α. CUT&RUN mapping of HNF1α DNA binding sites in primary human islets imputed a subset of HNF1α-regulated genes as direct targets. These data elucidate mechanistic links between HNF1A loss and diabetic phenotypes in mature human α and β cells.

Authors

Mollie F. Qian, Romina J. Bevacqua, Vy M.N. Coykendall, Xiong Liu, Weichen Zhao, Charles A. Chang, Xueying Gu, Xiao-Qing Dai, Patrick E. MacDonald, Seung K. Kim

×

Figure 2

HNF1A suppression leads to dysregulated insulin and glucagon secretion after 1 month in vivo.

Options: View larger image (or click on image) Download as PowerPoint

HNF1A suppression leads to dysregulated insulin and glucagon secretion ...
(A) Experimental approach for control and HNF1AKD pseudoislet transplantation under kidney capsules of NSG mice and characterization of graft phenotypes; 1,000 pseudoislets were transplanted per mouse. (B–D) Blood glucose, plasma human insulin levels, and AUC of insulin excursion upon i.p. glucose challenge after transplantation of pseudoislets to NSG mice (n = 4 mice, 3 human donors). (E) Schematic of pseudoislet transplantation to glucagon-KO mice on an NSG background (GKO-NSG) for characterization of glucagon phenotypes; 1,000 pseudoislets were transplanted per mouse. (F–K) Blood glucose, plasma glucagon levels, and AUC of glucagon excursion upon i.p. glucose (F–H) or insulin (I–K) challenge after transplantation to GKO-NSG mice (n = 4 mice, 4 human donors). Data are mean values ± SEM. Two-tailed t tests were used to generate P values; *P < 0.05, **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts